menu
    • menu

    Company profile for Vor Biopharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vor, the Norse goddess of wisdom, was known as “the careful one.” These qualities are reflected in Vor’s ability to leverage the cumulative knowledge around a variety of recent technologies to carefully craft a new generation of HSCs that are hidden from targeted therapies. Our logo represents the core components of our science — a new approach to hematopoietic stem cells (the crowning triangle) that allows targeted th...
    Vor, the Norse goddess of wisdom, was known as “the careful one.” These qualities are reflected in Vor’s ability to leverage the cumulative knowledge around a variety of recent technologies to carefully craft a new generation of HSCs that are hidden from targeted therapies. Our logo represents the core components of our science — a new approach to hematopoietic stem cells (the crowning triangle) that allows targeted therapies to distinguish between healthy and diseased cells and only attack the target protein (the diamond).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vor BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    215 First Street, Suite 430 Cambridge MA, 02142
    Telephone
    Telephone
    617-655-6580
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vorbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vor-biopharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vor Bio Announces $150 Million Private Placement
    Vor Bio Announces $150 Million Private Placement

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205359/0/en/Vor-Bio-Announces-150-Million-Private-Placement.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Vor Bio Reports Q3 2025 Financials & Corporate Update
    Vor Bio Reports Q3 2025 Financials & Corporate Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187807/0/en/Vor-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Vor Bio Plans $100M Public Stock Offering
    Vor Bio Plans $100M Public Stock Offering

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3185064/0/en/Vor-Bio-Announces-Proposed-Public-Offering-of-100-Million-of-Common-Stock.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Telitacicept Hits Primary Endpoint In Ph3 IgA Nephropathy Study
    Telitacicept Hits Primary Endpoint In Ph3 IgA Nephropathy Study

    08 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/08/3184078/0/en/Telitacicept-Achieved-Primary-Endpoint-of-Reducing-Proteinuria-in-Stage-A-of-a-Phase-3-Clinical-Study-for-IgA-Nephropathy-in-China.html

    GLOBENEWSWIRE
    08 Nov 2025
    Share Share
    Vor Bio To Participate In Upcoming Investor Conferences
    Vor Bio To Participate In Upcoming Investor Conferences

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183611/0/en/Vor-Bio-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Vor Bio Appoints Jeremy Sokolove, M.D. As Chief Medical Officer
    Vor Bio Appoints Jeremy Sokolove, M.D. As Chief Medical Officer

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179217/0/en/Vor-Bio-Appoints-Jeremy-Sokolove-M-D-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search